OCGN

Ocugen Inc. Healthcare - Biotechnology Investor Relations →

NO
12.0% ABOVE
↓ Approaching Was 21.3% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $1.19
14-Week RSI 42

Ocugen Inc. (OCGN) closed at $1.33 as of 2026-02-02, trading 12.0% above its 200-week moving average of $1.19. The stock is currently moving closer to the line, down from 21.3% last week. The 14-week RSI sits at 42, indicating neutral momentum.

Over the past 535 weeks of data, OCGN has crossed below its 200-week moving average 2 times. On average, these episodes lasted 260 weeks. The average one-year return after crossing below was -36.1%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $435 million, OCGN is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -289.9%. The stock trades at 120.9x book value.

Share count has increased 46.1% over three years, indicating dilution.

Over the past 10.3 years, a hypothetical investment of $100 in OCGN would have grown to $1, compared to $393 for the S&P 500. OCGN has returned -38.2% annualized vs 14.2% for the index, underperforming the broader market over this period.

Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: OCGN vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After OCGN Crosses Below the Line?

Across 2 historical episodes, buying OCGN when it crossed below its 200-week moving average produced an average return of -40.0% after 12 months (median -40.0%), compared to +8.0% for the S&P 500 over the same periods. After 24 months, the average return was -38.0% vs +32.0% for the index.

Each line shows $100 invested at the moment OCGN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

OCGN has crossed below its 200-week MA 2 times with an average 1-year return of +-36.1% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Nov 2015Sep 202551599.7%-36.1%-99.4%
Nov 2025Dec 202549.9%N/A+11.8%
Average260+-36.1%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02